January 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreApril 21, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreMay 18, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreApril 21, 2026
According to forecasts, the global berberine API market will grow from USD 523 million in 2024 to USD 973.13 million by 2034, with an expected CAGR of 6.45%.The berberine API market is growing due to its wide use in nutraceuticals, pharmaceuticals, and health supplements, as it has a wide range of pharmacological effects. Asia Pacific is dominant i...
April 21, 2026
Market insights predict, the topical antibiotic drug industry is expected to grow from USD 5.65 billion in 2024 to USD 9.59 billion by 2034, driven by a CAGR of 5.45%. The market is growing globally due to increasing skin infections, rising antimicrobial resistance awareness, and expanding use in post-surgical wound care. North America dominates th...
April 21, 2026
The seasonal vaccines market is expanding due to growing government initiatives as well as rising post-pandemic awareness. North America led the market due to the high healthcare investments....
April 21, 2026
The chemical synthesis peptide drugs market is valued at US$ 2.74 billion in 2025 and is projected to reach US$ 4.82 billion by 2034, growing at a CAGR of 6.54%. Key segments include synthesis methods (chemical, non-chemical), technologies (SPPS, LPPS, hybrid), product types (reagents, consumables, services), end-users (pharma, CDMOs/CROs), and app...
April 21, 2026
Based on market forecasts, the global pharmaceutical grade melatonin market, projected at USD 479.9 million in 2024, is expected to reach USD 1044.3 million by 2034, growing at a CAGR of 8.56% over the forecast period. The rising prevalence of sleep disorders and the burgeoning tourism sector drive the global market. The presence of key players and...
April 21, 2026
Market insights predict, the antitumor ADC drugs industry is expected to grow from USD 7.38 billion in 2025 to USD 24.75 billion by 2035, driven by a CAGR of 12.86%. Rising cancer incidence/unmet needs have driven the growth of the market. North America led the global market owing to a strong R&D pipeline & biopharmaceutical innovations in ...
April 21, 2026
The emerging need for oral medicines is due to the progression of diabetes, inadequate lifestyle management, and declining insulin production. North America dominated the market in 2024, driven by the growing aging population, innovative drug treatments, and improved access and affordability....
April 21, 2026
Projections indicate that, the global injection flu shot market will increase from USD 10.63 billion in 2024 to USD 29.97 billion by 2034, experiencing a CAGR of 10.93% over the next 10 years. The increasing number of elderly individuals, who are more susceptible to serve flu complications, has heightened the demand for the flu vaccines. North Amer...
April 21, 2026
According to forecasts, the global skin anesthetic cream market will grow from USD 2.35 billion in 2024 to USD 4.36 billion by 2034, with an expected CAGR of 6.36%. The skin anesthetic cream market is expanding due to the rising number of minimally invasive aesthetic procedures and growing over-the-counter (OTC) availability of numbing products for...
April 21, 2026
According to market projections, the global antipyretic and analgesic drugs market, valued at USD 47.47 billion in 2024, is anticipated to reach USD 77.99 billion by 2034, growing at a CAGR of 5.09% over the next decade. The rising prevalence of fever, headache, muscle pain, and inflammation-related conditions has driven the growth of the market. N...